• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Regulatory Information

  • Print
  • Share
  • E-mail

Attachment B: List of Agency Panel Members at the Hearing

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents

Previous Section: Attachment A: List of Presenters at the Hearing

Jane A. Axelrad 
Associate Director for Policy
Center for Drug Evaluation and Research, FDA

Mary Elizabeth Jacobs
Associate Director for Regulatory Affairs
Office of Blood Research and Review
Center for Biologics Evaluation and Research, FDA

William McConagha 
Associate Chief Counsel for Enforcement, FDA

Lana Ogram
Director, Division of Prescription Drug Compliance and Surveillance
Center for Drug Evaluation and Research, FDA

Margaret O'Rourke 
Senior Regulatory Expert, Prescription Drug Marketing Act
Center for Drug Evaluation and Research, FDA

Seth Ray
Associate Chief Counsel for Drugs, FDA

Toni Stifano
Associate Director for Labeling Policy and Medical Communication
Office of Compliance and Biologics Quality
Center for Biologics Evaluation and Research, FDA

John Taylor 
Director, Office of Enforcement
Office of Regulatory Affairs, FDA

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents

Next Section: Attachment C: List of Key Dates